ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Rush Cancer Institute at Rush University Medical Center

Include trials that are no longer recruiting patients.

4 studies were found.
1.No longer recruitingAmifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Conditions: untreated adult acute myeloid leukemia; Drug Toxicity; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
2.No longer recruitingCombination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Conditions: untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
3.No longer recruitingErlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
4.RecruitingTopotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Conditions: recurrent adult brain tumor; adult glioblastoma; adult anaplastic astrocytoma; adult giant cell glioblastoma; adult gliosarcoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act